Expert Video - What are the treatment options for MDS-related anemia?
MDS experts, Dr Rafael Bejar and Dr Casey O’Connell discuss typical treatment options for MDS-related anemia. In this video, the treatment and management options discussed are: surveillance and monitoring, erythropoiesis stimulating agents (ESAs), lenalidomide, ESAs in combination with lenalidomide, and an immune-type therapy called anti-thymocyte globulin (ATG).
Share with family and friends:
Click here to take our SURVEY Your feedback is important to us! We will use your feedback to develop future areas of content about MDS which will help other patients, caregivers and families.
This educational activity has been developed by the Myelodysplastic Syndromes Foundation, Inc. and Mechanisms in Medicine Inc.
This activity is supported by an educational grant from Acceleron Pharma, Bristol-Myers Squibb, Celgene Corporation, Jazz Pharmaceuticals, Novartis Pharmaceuticals, and Takeda Oncology.
This website is part of the Animated Patient™ series developed by Mechanisms in Medicine Inc., to provide highly visual formats of learning for patients to improve their understanding, make informed decisions, and partner with their healthcare professionals for optimal outcomes.